Identification of cleavage sites in the HIV-1 TAR RNA by 10-23 and 8-17 catalytic motif containing DNA enzymes

被引:10
作者
Chakraborti, S [1 ]
Banerjea, AC [1 ]
机构
[1] Natl Inst Immunol, Virol Lab, New Delhi 110067, India
关键词
D O I
10.1021/bm025698i
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A quick identification of a cleavage site in the target RNA molecule to obtain sequence-specific cleavage by either catalytic RNA (ribozymes) or DNA (DNA enzymes) is very important for achieving gene-specific suppression. These molecules could also provide important information on the secondary and tertiary structure of the target RNA molecule. We have exploited the use of two kinds of DNA enzymes, namely, the 10-23 and 8-17 catalytic motif containing DNA enzymes, to achieve these objectives. We identified several DNA enzyme cleavage sites in the human immunodeficiency virus type 1 (HIV-1) transactivation response element (TAR) RNA-a structural feature present at the 5' end of all HIV-1 transcripts. Most of the DNA enzymes that cleaved the TAR RNA were targeted to the regions that were single-stranded in the predicted structure. Regions that were predicted to be base-paired (stem) failed to show any detectable cleavage. The DNA enzyme possessing the 8-17 catalytic motif was extremely efficient in cleaving full length, as well as short, HIV-1 specific transcripts. The efficiency of cleavage of the same target RNA by DNA enzymes that possessed the 10-23 catalytic motif was significantly less in comparison, and they failed to cleave the short transcripts. These molecules, in principle, have the potential to down regulate expression of all HIV-1 transcripts from a wide range of isolates because this region is functionally very well conserved.
引用
收藏
页码:568 / 571
页数:4
相关论文
共 15 条
[1]   THE STRUCTURE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAR RNA REVEALS PRINCIPLES OF RNA RECOGNITION BY TAT PROTEIN [J].
ABOULELA, F ;
KARN, J ;
VARANI, G .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 253 (02) :313-332
[2]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[3]   REOVIRUS PROTEIN-SIGMA-1 TRANSLATED INVITRO, AS WELL AS TRUNCATED DERIVATIVES OF IT THAT LACK UP TO 2/3 OF ITS C-TERMINAL PORTION, EXISTS AS 2 MAJOR TETRAMERIC MOLECULAR-SPECIES THAT DIFFER IN ELECTROPHORETIC MOBILITY [J].
BANERJEA, AC ;
JOKLIK, WK .
VIROLOGY, 1990, 179 (01) :460-462
[4]   Targeted cleavage of HIV-1 coreceptor-CXCR-4 by RNA-cleaving DNA-enzyme: inhibition of coreceptor function [J].
Basu, S ;
Sriram, B ;
Goila, R ;
Banerjea, AC .
ANTIVIRAL RESEARCH, 2000, 46 (02) :125-134
[5]  
Gatignol A, 2000, Adv Pharmacol, V48, P209
[6]   Inhibition of hepatitis B virus X gene expression by novel DNA enzymes [J].
Goila, R ;
Banerjea, AC .
BIOCHEMICAL JOURNAL, 2001, 353 :701-708
[7]   DIVERSITY OF OLIGONUCLEOTIDE FUNCTIONS [J].
GOLD, L ;
POLISKY, B ;
UHLENBECK, O ;
YARUS, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :763-797
[8]   Tackling Tat [J].
Karn, J .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (02) :235-254
[9]   Deoxyribozymes: new players in the ancient game of biocatalysis [J].
Li, YF ;
Breaker, RR .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1999, 9 (03) :315-323
[10]   Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA [J].
Long, KS ;
Crothers, DM .
BIOCHEMISTRY, 1999, 38 (31) :10059-10069